30,080 opioid-related interventions, resulting in $7,338,100 in cost savings1
Consider the following:
Easy to Implement
At-risk employees identified: Employer group provides roster of eligible* employees to SinfoníaRx based on provided screening criteria
Self-referred option: Anonymous codes are provided for self-referred employees and family members
SinfoníaRx sends the employee a qualification letter
SinfoníaRx calls the employee to conduct a Comprehensive Medication Review
QC-MyMeds™ reports on activity and status of the program to the employer group
Periodic analysis of newly at-risk employee population
*Excludes Oregon and minors
References: 1. Data on file. Tucson, AZ: SinfoníaRx; 2018. 2. Druley K. Safety + Health. https://www.safetyandhealthmagazine.com/articles/16727-house-hearing-explores-employers-role-in-combating-opioid-crisis. Accessed July 26, 2019. 3. Meier B et al. The soaring cost of the opioid economy. New York Times. June 22, 2013. https://www.nytimes.com/interactive/2013/06/23/sunday-review/the-soaring-cost-of-the-opioid-economy.html. Accessed July 26, 2019.
Copyright 2019 QC-Health, Inc.